[1]
Ms. Jyoti Rani et al. 2024. AN ANALYSIS OF PROBLEMS OF SUKANYA SAMRIDDHI ACCOUNT SCHEME: INVESTORS’ PERSPECTIVE. Journal of Population Therapeutics and Clinical Pharmacology. 31, 5 (May 2024), 149–158. DOI:https://doi.org/10.53555/jptcp.v31i5.6096.